DYNAMICS OF CANCER CELL TRAFFIC IN THE LYMPHATIC SYSTEM
Project Number1R01CA038729-01
Contact PI/Project LeaderWEISS, LEONARD
Awardee OrganizationNEW YORK STATE DEPARTMENT OF HEALTH
Description
Abstract Text
Metastasis is of major importance in the diagnosis, staging, and treatment
of cancer. In the case of carcinomas, initially the lymphatic route of
dissemination is of particular importance, and in the later stages of
disease, the hematogenous routes become progressively more important.
Previous studies of the lung-to-liver and liver-to-lung traffic of cancer
cells via the blood-stream in mice and rats, have demonstrated that the
patterns of tumor growth are considerably modified by the interactions of
cancer cells with the vascular beds of the first organ they encounter after
gaining access to the blood-stream. However, analogous quantitative data
on the traffic of cancer cells in the lymphatic system is lacking. It is
proposed to obtain such dynamic data by introducing cancer cells into the
lymphatic system of rats and mice via foot-pad injections; via transplanted
subcutaneous tumors; and, in rats only, by direct intralymphatic injections
at carefully controlled rates. By means of direct cell counts, bioassays,
and the use of radiolabeled cancer cells, cancer cell traffic and viability
will be quantitated in an orderly anatomic manner by sampling from the
(prepopliteal) afferent lymph-vessels, the (popliteal) nodes, the
(post-popliteal) efferent lymph-vessels, the next lymph-nodes "in-line",
the venous blood by right ventricular puncture, and finally the lungs.
Cancer cell traffic through lymph-nodes containing cancers of the same type
will also be analyzed to differentially assess involved lymph-nodes as
filters and/or generalizing sites.
Although parts of the traffic of cancer cells with the lymphatic system
have been described separately, there appears to have been no
comprehensive, quantitative dynamic studies, as proposed here, on one of
the major metastatic routes. This information is vital for any
quantitation of the metastatic process. (L)
No Sub Projects information available for 1R01CA038729-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01CA038729-01
Patents
No Patents information available for 1R01CA038729-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01CA038729-01
Clinical Studies
No Clinical Studies information available for 1R01CA038729-01
News and More
Related News Releases
No news release information available for 1R01CA038729-01
History
No Historical information available for 1R01CA038729-01
Similar Projects
No Similar Projects information available for 1R01CA038729-01